Šajā tīmekļa vietnē tiek izmantotas sīkdatnes. Turpinot lietot šo vietni, jūs piekrītat sīkdatņu izmantošanai. Uzzināt vairāk.
Teksta versija
LEGAL ACTS OF THE REPUBLIC OF LATVIA
home
 
The translation of this document is outdated.
Translation validity: 30.08.2017.–16.05.2019.
Amendments not included: 07.05.2019.

Text consolidated by Valsts valodas centrs (State Language Centre) with amending regulations of:

26 June 2007 [shall come into force from 1 October 2007];
5 February 2008 [shall come into force from 9 February 2008];
2 June 2008 [shall come into force from 6 June 2008];
12 April 2011 [shall come into force from 1 June 2011];
22 October 2013 [shall come into force from 25 October 2013];
5 January 2016 [shall come into force from 15 January 2016];
29 November 2016 [shall come into force from 1 December 2016];
22 August 2017 [shall come into force from 30 August 2017].

If a whole or part of a paragraph has been amended, the date of the amending regulation appears in square brackets at the end of the paragraph. If a whole paragraph or sub-paragraph has been deleted, the date of the deletion appears in square brackets beside the deleted paragraph or sub-paragraph.


Republic of Latvia

Cabinet
Regulation No. 175
Adopted 8 March 2005

Regulations Regarding Manufacture and Storage of Prescription Forms, as well as Writing out and Storage of Prescriptions

[26 June 2007]

Issued pursuant to
Section 60 of the Medical Treatment Law and Section 36,
Paragraph one of the law On Procedures
for the Legal Trade of Narcotic and Psychotropic Substances
and Medicinal Products

[26 June 2007]

I. General Provisions

1. This Regulation prescribes the procedures for manufacture and storage of prescription forms (except veterinary prescriptions), as well as for writing out prescriptions.

2. There are the following prescriptions:

2.1. an ordinary prescription for writing out medicinal products to be issued for payment in full and medical devices, except for the medicinal products referred to in Sub-paragraph 2.2 of this Regulation. The ordinary prescription shall be written out electronically in the unified electronic information system of the health sector (hereinafter - the health information system) in conformity with laws and regulations regarding a unified electronic information system of the health sector or on the ordinary prescription form (Annex 1);

2.2. a special prescription for writing out narcotic and psychotropic medicinal products, also medicinal products which the State Agency of Medicines has recognised as narcotic analgesic agents, medicinal products which contain substances referred to in Annex 7 to this Regulation, as well as medicinal products and medical devices the purchase expenses of which shall be partly or completely compensated to the patient. The special prescription shall be written out electronically in the health information system in conformity with laws and regulations regarding a unified electronic information system of the health sector or on the special prescription form (Annex 2).

[5 January 2016]

3. Advertising is prohibited on a prescription (also on the reverse side of a prescription).

II. Manufacture and Storage of Prescription Forms

4. Prescription forms shall be printed typographically in accordance with Annexes 1 and 2 to this Regulation. Prescription series and sequence number shall also be printed typographically, ensuring that the series of the prescription forms, as well as the sequence numbers within a series do not repeat.

5. The size of a prescription form shall be 12 x 18 cm. The prescription form shall be printed on white-coloured paper with watermarks. The printed text shall be in black.

[26 June 2007]

6. The margins of the ordinary prescription form and the part to be completed by the pharmacy shall be coloured in light blue. The margins of the special prescription form and the part to be completed by the pharmacy shall be coloured in light red.

[2 June 2008]

7. The National Health Service (hereinafter - the Service) shall distribute the prescription forms to the medical treatment institutions and medical practitioners. In accordance with the laws and regulations regarding procurement for State needs the Service shall organise the manufacture of prescription forms, as well as typographic printing thereof providing for the incorporation of the safeguards referred to in Paragraphs 5 and 6 of this Regulation in order to prevent the possibility of forgery of the prescription forms.

[22 October 2013]

8. A merchant which typographically prints the prescription forms in accordance with an agreement entered into with the Service shall ensure the storage of the prescription forms and originals of photo materials used for the manufacture of the prescription forms so as to prevent unauthorised persons from accessing them. The merchant shall transfer to the Service the typographically printed prescription forms together with an invoice, as well as the originals of photo materials used for the manufacture of the prescription forms. The merchant shall transfer to the Service the defective prescription forms by drawing up an act of transfer.

[12 April 2011; 22 October 2013]

9. The director of the Service shall assign an official (hereinafter - the responsible official) who shall be responsible for:

9.1. the receipt of prescription forms from the merchant which prints the prescription forms, the registration thereof, the storage and issuing to medical treatment institutions and medical practitioners;

9.2. the receipt and storage of the originals of photo materials used for the manufacture of the prescription forms, taking into account that the originals of photo materials used for the manufacture of ordinary prescription forms shall be stored for one year, but originals of photo materials used for the manufacture of special prescription forms - for three years; and

9.3. the registration and destruction of defective and withdrawn from circulation prescription forms.

[12 April 2011; 22 October 2013]

10. The head of a medical treatment institution shall ensure and shall be responsible for the storage, accounting of prescription forms and issuance to medical practitioners who work for the relevant medical treatment institution, as well as for the accounting, storage and destruction of unused special prescriptions which have been written out on a prescription form and, in accordance with Paragraph 25 of this Regulation, have been returned from patients (hereinafter - the unused prescription), and for the accounting and transfer to the Service of the prescription forms withdrawn from circulation by drawing up an act of transfer thereof.

[5 January 2016]

11. In order to ensure accounting of prescription forms and circulation control in the institution, the special prescription forms shall be registered in a registration journal for special prescription forms in the Service and medical treatment institution. The format of the registration journal for special prescription forms shall be determined by the director of the Service and the head of the medical treatment institution accordingly. The registration journal for special prescription forms shall be completed not less than once a week.

[5 January 2016]

12. The Service shall keep the special prescription forms and the originals of photo materials thereof in a safe equipped with an alarm system which is located in a room ensured against entrance of unauthorised persons and equipped with an alarm system. The ordinary prescription forms and the originals of photo materials thereof, as well as defective and withdrawn from a circulation prescription forms shall be kept in a room which is ensured against entrance of unauthorised persons, observing that the defective and withdrawn from circulation prescription forms shall be kept separately until the destruction thereof in order to prevent confusion with valid prescription forms.

[12 April 2011; 22 October 2013]

13. A responsible official shall ensure the issuance of prescription forms upon a request approved by the head of a medical treatment institution (signature of the head of the medical treatment institution and stamp of the medical treatment institution). The requisites of the medical treatment institution, date of request, request number, number and type of prescription forms shall be indicated in the request. Ordinary prescription forms shall be issued also upon a doctor's written request. Given name, surname, diploma number, address, phone number of the doctor, the number of prescription forms, date of request shall be indicated in this request, as well as a signature certifying the information indicated. A request of special prescription forms shall be valid for seven days. The Service shall store a request of special prescription forms for three years, a request of ordinary prescription forms - for one year.

[12 April 2011; 22 October 2013]

14. A responsible official shall ensure that the number of prescription forms issued, the series and numbers of the issued prescriptions, the date of issuance of prescription forms, as well as the issuer (given name, surname) shall be indicated on the request of ordinary prescription forms. The issuer and the recipient shall certify the referred to information with a signature.

15. The Service shall issue prescription forms to a person who acts on behalf of the head of a medical treatment institution with an authorisation approved by the head of the medical treatment institution. An official entitled to receive special prescription forms, date of issuance of the authorisation and number thereof, as well as the term of validity of no more than seven days shall be indicated in the authorisation. The official shall submit the authorisation and present a personal identification document upon receipt of prescription forms, as well as submit a guarantee letter if payment is made by transfer. A doctor shall present a personal identification document, diploma attesting his or her education or a doctor's certificate upon receipt of ordinary prescription forms for prescribing medicinal products for personal use. A doctor's assistant (paramedic) shall present a personal identification document, diploma attesting his or her education or a doctor assistant's (paramedic's) certificate upon receipt of ordinary prescription forms for prescribing medicinal products for personal use.

[12 April 2011; 22 October 2013; 22 August 2017]

16. Prescription forms received form the Service, as well as the prescription forms withdrawn form circulation until the transfer thereof to the Service, and the unused prescriptions until the destruction thereof shall be stored in a medical treatment institution in a safe equipped with an alarm system which is placed in a room ensured against entrance of unauthorised persons by observing that the prescription forms withdrawn form circulation and the unused prescriptions are stored separately in order to prevent confusion thereof with valid prescription forms. A medical practitioner shall ensure the storage of the received prescription forms so that unauthorised persons may not access them. The safe may not be equipped with an alarm system if it is placed in a room equipped with an alarm system where a permanent connection to alarm system is ensured.

[26 June 2007; 12 April 2011; 22 October 2013]

17. Defective, damaged, withdrawn from circulation prescription forms and unused prescriptions shall be registered in a registration journal of invalid prescription forms and in a prescription registration journal in order to ensure the accounting of prescription forms and circulation control, including making an annotation regarding the destruction of prescription forms or prescriptions and the transfer of withdrawn from circulation prescription forms to the Service (act number and date). The format of the registration journal of invalid prescription forms and the prescription registration journal shall be determined by the director of the Service and the head of the medical treatment institution accordingly.

[26 June 2007; 12 April 2011; 22 October 2013]

18. The pages of the registration journals referred to in Paragraphs 11 and 17 of this Regulation (hereinafter - the registration journal) shall be numbered and bound together. Prior to making the first entry the head of the relevant institution shall approve the registration journals with a signature and the stamp of the institution.

19. Entries in the registration journals shall be numbered and they shall be made without leaving blank spaces and deleting entries. Corrections shall be certified with words "Labotam ticēt" [Correction valid], a signature of the responsible official or the head of the medical treatment institution and a stamp of the relevant institution.

20. A head of a medical treatment institution and the Service shall establish a commission (including employees of the relevant institution therein) which shall, once a month, inspect how the procedures for storage of prescription forms are complied with in the institution, as well as shall, not less than once in a quarter, carry out an inventory of prescription forms. The commission shall draw up an inventory act regarding the results of the inspection. The institution shall keep an inventory act for three years.

[12 April 2011; 22 October 2013; 5 January 2016]

21. If a shortage or a surplus of the special prescription forms is detected, a theft, robbery has occurred, or the losses have been caused due to a natural disaster, the relevant safe shall be sealed and the Health Inspectorate, as well as the State Police (if a theft or robbery has occurred) shall be notified immediately of the fact.

[26 June 2007; 5 February 2008]

22. In the case referred to in Paragraph 21 of this Regulation the head of the institution shall establish a commission. The commission shall consist of:

22.1. the head of the institution or his or her authorised official;

22.2. the responsible official (if the incident occurred in the Service); and

22.3. a representative of the Health Inspectorate.

[5 February 2008; 12 April 2011; 22 October 2013]

23. The commission referred to in Paragraph 22 of this Regulation shall draw up an act. The type of incident, the prescription form series, numbers, quantity, date of drawing up of the act and commission members (given name, surname and position) shall be indicated in the act. The act shall be drawn up in two copies and all the members of a commission shall sign it. The first copy of the act shall remain in the medical treatment institution or the Service (if the incident has occurred in the Service), and the second copy shall be transferred to the Health Inspectorate. If a shortage of prescription forms has been determined (also theft or robbery), the Health Inspectorate shall notify pharmacies regarding the series and numbers of the relevant prescription forms.

[5 February 2008; 12 April 2011; 22 October 2013]

24. Defective prescription forms and prescription forms withdrawn from circulation at the Service, damaged prescription forms and unused prescription forms at a medical treatment institution shall be destroyed in the presence of a commission (consisting of at least two persons) established by the head of the Service or the medical treatment institution accordingly. An act shall be drawn up regarding the destruction of prescription forms or prescriptions by indicating the type, series, numbers, quantity of the prescription forms or prescriptions destroyed, the place of destruction, date, destruction method, other conditions related to destruction, as well as the commission members (given name, surname and position). All members of the commission shall sign the act. The act shall be stored in the Service or medical treatment institution accordingly for three years.

[5 January 2016]

25. When writing out a special prescription for purchase of narcotic or equivalent psychotropic medicinal products, a medical practitioner shall notify the patient that the unused special prescriptions written out on a special prescription form shall be returned to the medical treatment institution in which they have been written out.

[5 January 2016]

26. Special prescriptions on which narcotic or psychotropic medicinal products equivalent thereto have been written out shall be stored at a pharmacy for five years, while other special prescriptions shall be stored for three years. Ordinary prescriptions shall be stored at a pharmacy for one year. Prescriptions written out in the European Union, European Economic Area states and the Swiss Confederation shall be kept in the pharmacy for three years.

[22 October 2013]

27. A patient shall store the multiple-use prescription referred to in Paragraph 35 of this Regulation and which is written out on an ordinary prescription form until the entire amount of medicinal products prescribed is received, or, with the consent of the patient, the pharmacy in which the patient shall further receive the medicinal products prescribed on the prescription. If the pharmacy stores the prescription, it shall without delay inform the patient regarding a change in the location of the pharmacy or other circumstances which may influence the accessibility of the medicinal products written out on the prescription for the patient. If the patient does not leave the multiple-use prescription in the pharmacy, the pharmacy shall ensure the registration of the prescription data and information regarding medicinal products issued in such a way that ensures the possibility of the Health Inspectorate to examine the justification for the issuing of the medicinal products. After the whole quantity of the prescribed medicinal products has been issued, the pharmacy at which the last purchase was made shall keep the prescription.

[2 June 2008; 5 January 2016]

28. [Not in force from 1 July 2009. See Paragraph 55.3]

III. Procedures for Writing out Prescriptions

29. A prescription shall be written out electronically in the health information system in conformity with laws and regulations regarding a unified electronic information system of the health sector or on the forms of a specific sample (Annexes 1 and 2) by taking into account the procedures for writing out prescriptions laid down in this Chapter and the requirements for filling out the prescriptions referred to in Annex 3 to this Regulation. When writing out the prescription electronically in the health information system, the procedures for writing out prescriptions in the health information system laid down in Chapter III.1 of this Regulation shall also be complied with additionally. A prescription shall only be written out on the form of a specific sample if:

29.1. medical devices, medicinal products of M list or medicinal products to be individually compensated in conformity with laws and regulations regarding the procedures for compensation of expenses for purchase of medicinal products and medical devices intended for out-patient treatment (hereinafter - the compensation procedures) are prescribed;

29.2. the patient has informed that a prescription will be used in another Member State of the European Union, any of the European Economic Area state or the Swiss Confederation;

29.3. a prescription is written out for a person who is not registered in the Population Register;

29.4. a doctor or a doctor's assistant (paramedic) who is not working in a medical treatment institution is prescribing medicinal products for personal use;

29.5. writing out a prescription in the health information system is not possible due to technical reasons - the health information system is not available, there is interruption in electricity or Internet connectivity in the doctor's practice, or it is not possible to access the health information system during a visit at home, and medicinal products or medical devices are immediately necessary for a patient;

29.6. the purchase of medicinal products is compensated by an insurance company for a patient.

[5 January 2016; 22 August 2017]

30. A prescription on specific sample forms shall be written out in a clearly legible handwriting or by using a computer, or other technical means which ensure clear and unmistakable data perception. A medical practitioner is prohibited to receive and store prescription forms on which the name of medicinal products is indicated. Prescription requisites and text shall be clearly legible and indelible. Mistakes and corrections are not allowed in writing out a prescription.

[5 January 2016]

31. Medicinal products and medical devices for primary and secondary out-patient treatment shall be written out on prescriptions. It is prohibited to prescribe medicinal products and medical devices for provision of a doctor's practice.

32. A doctor and doctor's assistant (paramedic) who works at a medical treatment institution have the right to write out an ordinary prescription. A doctor who does not work at a medical treatment institution is permitted to prescribe medicinal products on the ordinary prescription for personal use only, however no more than 50 prescriptions per year. A doctor's assistant (paramedic) who does not work at a medical treatment institution is permitted to prescribe medicinal products on the ordinary prescription for personal use only, however no more than 30 prescriptions per year.

[5 January 2016; 22 August 2017]

33. Only a doctor who works at a medical treatment institution has the right to write out a special prescription. Only a doctor who has entered into contractual relations with the Service has the right to prescribe medicinal products and medical devices the expenses of the purchase of which are partially or completely covered from the funds allocated for the compensation of the expenses of purchase of medicinal products in conformity with the procedures for compensation.

[2 June 2008; 12 April 2011; 22 October 2013; 5 January 2016]

34. Only a narcologist may prescribe medicinal products that contain buprenorphine to a patient to whom the State limited liability company "Rīgas psihiatrijas un narkoloģijas centrs" [Rīga Psychiatric and Narcology Centre] has issued a programme card of buprenorphine substitution therapy. The narcologist shall also indicate in the referred to programme card information regarding the name, dose, amount of medicinal products prescribed, the date of prescribing and the prescription number. The prescription for the supply of the medicinal product which contains buprenorphine shall be prescribed for the patient not more often than once every two weeks.

[26 June 2007]

34.1 Medicinal products which in accordance with laws and regulations regarding the procedures for medicinal product classification are intended for out-patient medical treatment, but which may cause serious side-effects due to which for the use thereof is needed an instruction from the relevant medical treatment specialist and supervision for the whole of the period of medical treatment, and for which is applied the marking "Pr. II" with an indication from the specialist doctor, may be prescribed only by the indicated specialist doctor.

[26 June 2007]

34.2 In prescribing medicinal products the use of which may cause a heightened risk to health or for which in accordance with Article 9(4)(c) of Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency additional risk reduction measures have been laid down (conditions or restrictions with regard to the safe and effective use of such medicinal products), the risk reduction measures for safe and effective use of the particular medicinal products developed by the holder (owner) of the medicinal product registration certificate and co-ordinated with the State Agency of Medicines shall be complied with.

[12 April 2011]

34.3 Medicinal products which contain the substances referred to in Annex 7 to this Regulation shall be prescribed by complying with the programme for avoiding pregnancy developed by the holder (owner) of the medicinal product registration certificate and co-ordinated with the State Agency of Medicines and the following conditions:

34.3 1. before the commencement of treatment a doctor shall ascertain that a patient has become acquainted with the programme for avoiding pregnancy (in conformity with a gender and reproductive potential of the age) and has signed informed consent document;

34.3 2. the medicinal products which contain isotretinoin, thalidomide, lenalidomide, acitretine and pomalidomide may be prescribed for patients with reproductive potential not more than for a treatment course of four weeks.

[5 January 2016; 29 November 2016]

34.4 The State Agency of Medicines shall post on the website (http://www.zva.gov.lv) the list of those medicinal products for which the holder (owner) of the medicinal product registration certificate has developed risk reduction measures and co-ordinated them with the State Agency of Medicines. The holder (owner) of the medicinal product registration certificate shall ensure the availability of the materials of risk reduction measures developed and co-ordinated with the State Agency of Medicines to doctors who have the right to prescribe the relevant medicinal products.

[12 April 2011]

35. If a doctor, when writing out an ordinary prescription, intends a possibility for a patient to purchase medicinal products on a regular basis by receiving the quantity of the prescribed medicinal products in parts not more than once a month, the doctor shall specify on the prescription "For a treatment course" and such prescription is considered to be a multiple-use prescription. If the prescription is written out on an ordinary prescription form, the doctor shall confirm the indication "For a treatment course" with a signature and personal stamp.

[5 January 2016]

36. Medicinal products and medical devices shall be prescribed on a single ordinary prescription for a treatment course of no more than three months, with the exception of the medicinal products referred to in Annex 4 to this Regulation which a doctor may prescribe on a multiple-use prescription referred to in Paragraph 35 of this Regulation for a treatment course of up to one year.

[5 January 2016]

37. It is permitted to prescribe only one medicinal product or medical device on the special prescription, providing the quantity of secondary packaging (hereinafter - the packaging) for a treatment course of not more than three months.

[5 January 2016]

38. In writing out a prescription for purchase of narcotic and equivalent psychotropic medicinal products a doctor shall not exceed the maximum amount of narcotic and equivalent psychotropic substances specified in Annex 5 to this Regulation permitted to be prescribed on a single prescription.

39. In writing out a prescription for the supply of psychotropic medicinal products (except in the case referred to in Paragraph 38 of this Regulation) and of narcotic analgesic products, the doctor shall prescribe a medicinal product for a medical treatment course of up to one month. A psychiatrist, narcologist, neurologist and family doctor, within the scope of the procedures for compensation, may prescribe the referred to medicinal products for a medical treatment course of up to three months.

[26 June 2007]

40. If a medical practitioner prescribes narcotic or psychotropic medicinal products for a patient, or medicinal products which the State Agency of Medicines has recognised as narcotic analgesic agents, he or she shall make an entry in the out-patient's card and indicate the name, dose, amount of the relevant medicinal products and the date of prescribing thereof. The head of the medical treatment institution shall ensure the inspection of the therapeutic justification and correctness of prescribing of the referred to medicinal products not less than once a month.

41. A medical practitioner shall use an ordinary prescription for dispensing an alcohol or aqueous solution thereof. Not more than 150g of alcohol of 96% or aqueous solution of alcohol, or pharmacy-prepared medicinal products containing no more than 150g of alcohol of 96%, shall be written out on a prescription.

[5 January 2016]

42. The following narcosis agents are prohibited from prescribing on prescriptions:

42.1. GHB (sodium oxybutirate and lithium oxybutirate);

42.2. fentanyl injection solution;

42.3. diethyl ether;

42.4. etomidate emulsion for injections;

42.5. isoflurane inhalation vapour, liquid;

42.6. medicinal nitric oxide, inhalation gas;

42.7. propofol emulsion for injections;

42.8. sevoflurane inhalation vapour, liquid;

42.9. thiopental powder for solution for injection.

[12 April 2011]

43. In writing out a prescription, only the prescription abbreviations in Latin referred to in Annex 6 to this Regulation are permitted.

44. A prescription written out in the health information system shall be approved in accordance with the laws and regulations regarding a unified electronic information system of the health sector. A medical practitioner shall approve a prescription written out on an ordinary prescription form by a signature and a personal stamp. A prescription written out on a special prescription form shall require a stamp of the medical treatment institution additionally (practice doctors may use a personal stamp which includes the requisites of a doctor's practice).

[5 January 2016]

45. If a medical practitioner, in cases specified in the Pharmaceutical Law, writes out a prescription for the purchase of medicinal products not included on the list of medicinal products registered in the Republic of Latvia, he or she shall notify the patient regarding the procedure for purchase of these medicinal products.

46. A medical practitioner who writes out a prescription on the basis of a request of a patient shall issue a true copy or a copy of the prescription. A pharmacy is prohibited from dispensing medicinal products or medical devices on the basis of a true copy or copy of a prescription.

[2 June 2008]

47. A medical practitioner is prohibited from issuing incomplete or partially completed prescription forms to a patient, except in the cases referred to in Annex 3 to this Regulation, when certain prescription requisites may not be indicated.

48. The term of validity of the special prescription shall be 90 days. The term of validity of an ordinary prescription shall be three months, except:

48.1. the prescription on which the medicinal products referred to in Paragraph 34.3 of this Regulation are prescribed and for which the term of validity is seven days; and

48.2. the multiple-use prescription referred to in Paragraph 36 of this Regulation the term of validity of which (not exceeding one year) shall be determined by a doctor.

[26 June 2007; 22 October 2013]

III.1 Procedures for Writing out Prescriptions in the Health Information System

[5 January 2016]

48.1 A prescription shall be written out in the health information system in accordance with the requirements for filling out the prescriptions laid down in Chapter III of and Annex 3 to this Regulation in so far as electronic prescriptions are concerned. When writing out an electronic prescription, the name of medicinal products shall be selected from the classifiers of medicinal products offered in the health information system, but the composition or name of the medicinal products to be manufactured according to individual prescription and name of the medicinal products not registered in Latvia shall be provided in the free text box of the health information system.

[5 January 2016]

48.2 When writing out an electronic prescription, a doctor or a doctor's assistant (paramedic) shall issue an identification number of the prescription upon request of the patient.

[22 August 2017]

48.3 In order to purchase the medicinal products written out on an electronic prescription, a person shall present a personal identification document to a pharmacist or pharmacist's assistant. If medicinal products are purchased by a person to whom the prescription has not been written out but who is authorised to process the personal data in the health information system of the person to whom the prescription has been written out, the person shall present his or her personal identification document to a pharmacist or pharmacist's assistant and provide the given name and surname of the person to whom the prescription has been written out. In other cases when medicinal products are acquired by a person to whom the prescription has not been written out, he or she shall present the identification number of the prescription to a pharmacist or pharmacist's assistant and provide the given name and surname of the person to whom the prescription has been written out. If the given name, surname of the provided person fails to match the information available in the health information system, the pharmacist or pharmacist's assistant shall not dispense the medicinal products. The pharmacist or pharmacist's assistant shall indicate in the health information system the given name, surname and personal identity number of the person who purchased the medicinal products prescribed on the electronic prescription.

[5 January 2016; 22 August 2017]

48.4 A patient has the right to purchase medicinal products prescribed on an ordinary electronic prescription in parts from one or several pharmacies.

[5 January 2016]

48.5 Special electronic prescriptions on which narcotic or psychotropic medicinal products equivalent thereto to be controlled in Latvia have been prescribed shall be stored in the health information system for five years, but other special prescription shall be stored in the health information system for three years. Ordinary prescriptions shall be stored in the health information system for one year.

[5 January 2016]

48.6 A pharmacy shall not dispense the medicinal products prescribed on the prescription if the information attesting that the person to whom the prescription has been written out is deceased is available in the health information system.

[5 January 2016]

48.7 If it is not possible to access the health information system during a visit at home, a doctor or a doctor's assistant (paramedic) has the right to write out an electronic prescription not later than on the next working day by informing the patient thereof during the visit.

[5 January 2016]

IV. Duties of Pharmacies and State Authorities Regarding the Circulation of Prescriptions and Prescription Forms

49. If medical devices and medicinal products of M list are prescribed on special prescription forms, a pharmacy shall, in accordance with the agreement regarding data processing of prescriptions, electronically provide the following information indicated on the special prescription form or a document approving payment (cashier cheque, receipt) to the Service:

49.1. the prescription series and number;

49.2. E form type (if a prescription has been written out to a citizen of another European Union Member State, Norway, Iceland, Liechtenstein or Switzerland in accordance with the international agreement providing for mutual settlements for the health services rendered);

49.3. the date the prescription was written out;

49.4. given name, surname and personal identity number of the patient (for the person presenting E or S form - an identification number);

49.5. name of the medical treatment institution;

49.6. given name, surname, personal identity number and speciality of a doctor;

49.7. code of diagnosis;

49.8. compensation percentage to be applied in accordance with the compensation procedure specified;

49.9. name of insurance company (if an insurance company compensates the patient for the purchase of medicinal products);

49.10. name of medicinal products prescribed;

49.11. code and quantity (number of packages) of the medicinal products dispensed. The price for one packaging, the amount intended for payment (taking into account the number of packages) and the allocation thereof between patient and another payer shall be indicated for the medicinal products distributed within the scope of the procedures for compensation; and

49.12. date of dispensing of medicinal products.

49.13. it is allowed or prohibited to substitute the medicinal products;

49.14. the presence of the statement issued by the social service office of the local government which attests for conformity with the status of a family (person) in need or conformity with the status of a person or family living separately which is entitled to exemption from a patient's co-payment for medicinal products and medical devices in accordance with laws and regulations regarding the procedures for compensation of expenses for purchase of medicinal products and medical devices intended for out-patient treatment.

[26 June 2007; 2 June 2008; 12 April 2011; 22 October 2013; 5 January 2016 / Amendment to Clause as regards to replacement of the words "If medicinal products and medical devices" with the words "If medical devices and medicinal products of M list" shall come into force on 1 December 2016. See Paragraph 2 of amendments]

49.1 If the medicinal products the expenditures for the acquisition of which are partially or completely covered by the funds from the State budget are prescribed on a special prescription form, except for the cases referred to in Sub-paragraph 29.1 of this Regulation, the pharmacy shall, in accordance with laws and regulations regarding a unified electronic information system of the health sector, provide information regarding prescribed and issued medicinal products online. If the medicinal products are prescribed on an ordinary prescription form, except for the cases referred to in Sub-paragraphs 29.3 and 29.4 of this Regulation, the pharmacy shall, in accordance with laws and regulations regarding a unified electronic information system of the health sector, be entitled to provide information regarding prescribed and dispensed medicinal products upon request of the patient online.

[29 November 2016, 22 August 2017/ New wording of Paragraph shall come into force on 1 September 2017. See Paragraph 60]

49.2 If a prescription is written out electronically in the health information system, the pharmacy shall, in accordance with laws and regulations regarding a unified electronic information system of the health sector, provide data regarding the dispensed medicinal products online.

[5 January 2016/ Paragraph shall come into force on 1 December 2016. See Paragraph 59]

50. The Service shall:

50.1. accumulate and process the data of the prescriptions referred to in Paragraph 49 of this Regulation;

50.2. upon the request of the Ministry of Health, the State Agency of Medicines, the Health Inspectorate and law enforcement institutions provide information regarding the consumption of the medicinal products and medical devices prescribed or dispensed on the prescriptions;

50.3. upon the request of the Ministry of Health, the Health Inspectorate and law enforcement institutions provide information regarding the writing out of the special prescriptions.

[2 June 2008; 12 April 2011; 22 October 2013; 5 January 2016]

51. The Health Inspectorate shall control the compliance with the procedures for circulation of prescription forms in the Service and medical treatment institutions, as well as the compliance with the procedures for circulation of prescription forms in pharmacies.

[5 February 2008; 12 April 2011; 22 October 2013]

52. [5 February 2008]

V. Closing Provisions

53. Special prescription forms and prescription forms on which medicinal products for differentiated payment are prescribed, which have been printed before the day this Regulation come into force may be used up to 15 June 2005.

54. Ordinary prescription forms printed before the day this Regulation come into force may be used up to 30 June 2005.

55. Cabinet Regulation No. 250 of 14 July 1998, Regulations Regarding Manufacture and Storage of Prescription Forms and Writing Out Prescription Forms (Latvijas Vēstnesis, 1998, No. 212/213; 2001, No. 7; 2003, No. 167), is repealed.

55.1 [5 January 2016]

55.2 The prescribing of medicinal products and medical devices on prescription forms which are printed up to 30 September 2007 shall be permitted up to 1 May 2008.

[26 June 2007]

55.3 Paragraph 28 of this Regulation shall be repealed from 1 July 2009.

[2 June 2008]

55.4 The prescribing of medicinal products without indicating the code of the prescribed medicinal product and medical devices on special prescription forms which have been printed up to 31 December 2008 shall be permitted up to 30 June 2009.

[2 June 2008]

56. Paragraphs 49 and 50 of this Regulation shall come into force on 1 July 2005.

57. The prescription forms which are printed until 25 October 2013 shall be permitted to be distributed until 1 July 2014.

[22 October 2013]

58. Prescribing medicinal products and medical devices on prescription forms which are printed until 25 October 2013 shall be permitted by 31 December 2014. From 1 January 2014, when prescribing medicinal products and medical devices, the word "(lats)" shall be deleted in the abovementioned forms.

[22 October 2013]

59. Paragraph 49.2 of this Regulation shall come into force on 1 December 2016.

[5 January 2016; 29 November 2016]

60. Paragraph 49.1 of this Regulation shall come into force on 1 September 2017. Until 31 August 2017 a pharmacy shall provide the information electronically in accordance with the agreement on processing of prescription data to the Service in accordance with Paragraph 49 of this Regulation regarding the medicinal products the expenditures for the acquisition of which are partially or completely covered by the funds from the State budget and which are prescribed on special prescription forms.

[29 November 2016]

61. Until 30 November 2016 a prescription shall be written out electronically in the health information system in accordance with the following procedures: all columns provided in the electronic prescription which apply to the particular case shall be filled out, after filling out it shall be printed out on an ordinary prescription form if the ordinary prescription is written out, or on a special prescription form if the special prescription is written out, it shall be approved by a signature and personal stamp, but the special prescription also by a stamp of the medical treatment institution (practice doctors may use a personal stamp which includes the requisites of a doctor's practice) and shall be issued to a patient.

[5 January 2016]

62. The procedures for manufacture and storage of prescription forms laid down in Chapter II of this Regulation shall be applied to the prescriptions written out in accordance with Paragraph 61 of this Regulation.

[5 January 2016]

Informative Reference to the European Union Directives

[5 January 2016]

This Regulation contains legal norms arising from:

1) Commission Implementing Directive 2012/52/EU of 20 December 2012 laying down measures to facilitate the recognition of medical prescriptions issued in another Member State;

2) Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use.

Prime Minister A. Kalvītis

Minister for Health G. Bērziņš

 

Annex 1
Cabinet Regulation No. 175
8 March 2005

[22 October 2013]

Sample of the Ordinary Prescription Form

 

Annex 2
Cabinet Regulation No. 175
8 March 2005

[22 October 2013]

Sample of the Special Prescription Form

 

Annex 3
Cabinet Regulation No. 175
8 March 2005

Requirements for Filling out the Prescriptions

[26 June 2007; 2 June 2008; 22 October 2013; 5 January 2016; 22 August 2017]

I. General Requirements

1. [26 June 2007]

2. The introductory part of the prescription (Inscriptio) shall indicate:

2.1. the date of writing out of the prescription;

2.2. the given name, surname (indicate full name without using initials), personal identity number (for a person presenting E or S form - identification number) and address or telephone number of the patient. When writing out an ordinary prescription for personal use a doctor in place of the given name and surname of the patient shall write "pro me" (for me) or "ad usum proprium" (for personal utilisation), in the place for the address shall indicate his or her actual place of residence address and telephone number;

2.3. the name, code, address and telephone number of the medical treatment institution; and

2.4. the given name, surname (indicate full name without using initials), speciality and personal identity number or identifier of the medical practitioner assigned by the Health Inspectorate of the medical practitioner who writes out the prescription.

3. In the address part (Invocatio) shall write "Rp.:" (Recipe - take).

4. In the prescription part (Praescriptios. Designatio materiarum) after "Rp.:" the form of the medicinal products, the name with a capital letter in Latin in genitive case shall be written, indicating the dose of the form of medicinal products and number of doses.

5. For medicinal products with compound composition to be made upon individual prescriptions:

5.1. the name of each medicinal product substance shall be written in a separate line, listing the narcotic, psychotropic and other substances subject to strict registration first, then the remaining substances of great virtue and other active substances;

5.2. if the name of the medicinal product substance is long, it is permissible to continue with it also on the next line;

5.3. the first word of the names of medical treatment herbs shall be written with a capital letter even if they are not at the beginning of the line, but the designation of the part of the herb in this case shall be written with a small letter;

5.4. if any correcting substances have been added to the medicinal products due to the organoleptic property thereof, they shall be listed after active substances; and

5.5. ancillary substances, which ensure the necessary consistency, form and amount of the medicinal products, shall be listed last on the prescription.

6. The amount in mass, capacity or operation units shall be written on the right side of the prescription opposite to the name of the relevant medicinal product ingredient:

6.1. for medicinal product substances of hard or soft consistency - in grams or in fractions of a gram, writing them as unnamed figures;

6.2. for liquids - in millilitres, adding the abbreviation "ml" after the figure;

6.3. the amount of alcohol shall be written out in grams, indicating the concentration of the alcoholic solution;

6.4. the number of drops shall be designated with Roman numerals, writing it after the abbreviation "gtt.";

6.5. the number of operation units shall be indicated for the active substances of the drug agent, after which the abbreviation "DV" shall be written.

7. If two or more medicinal product ingredients shall be taken in equal amounts, this may be indicated only after the last of these ingredients by writing "āā" before the amount.

8. Indicating the last medicinal product ingredient to be added in order to obtain the required total mass or capacity of the medicinal products, the abbreviation "ad" shall be used before the numerical amount designation.

9. Instructions to the dispensing pharmacy (Subscriptio) regarding the making up of the medicinal products, the form and amount of medicinal products, indicating the mass or capacity, or operation units, and the type of package, shall be written in Latin, using generally accepted prescription abbreviations in accordance with Annex 6 to this Regulation.

10. Instructions to the patient (Signatura) regarding medicinal product usage shall be written in Latvian after the abbreviation "D.S.", indicating the doses, when, how often and how the medicinal products shall be used.

11. If medicinal products written out on a prescription shall be made up and dispensed urgently, the medical practitioner shall write the note "Cito!" If medicinal products shall be dispensed immediately, the note "Statim!" shall be written. It is recommended to indicate the note in another colour.

12. If it is prohibited to substitute the medicinal products, the medical practitioner shall strike off crosswise the area "Zāles atļauts aizvietot" [It is permitted to substitute the medicinal products] and indicate justification of such prohibition. The other side of the prescription may be used for continuation of the indication of justification by using designation "verte".

13. The medical practitioner shall strike off crosswise all areas of the prescription form which, in the specific case, are not intended to be filled out.

13.1 When issuing biological medicinal products, a pharmacist or pharmacist's assistant shall indicate a serial number of the issued medicinal products on the reverse side of the prescription form if the prescription is written out on a prescription form, or in the health information system if the prescription is written out in the health information system. A pharmacist or pharmacist's assistant shall approve this information on the prescription form by a signature and personal stamp.

II. Requirements for Filling out Ordinary Prescriptions

14. If a medical practitioner intends for an option to select one of the analogue medicinal products when writing out an ordinary prescription, he or she shall indicate several medicinal products, separating them with the abbreviation "s." (sive - or), and one of the medicinal products prescribed shall be dispensed at a pharmacy.

15. [1 October 2017. See Paragraph 3 of amendments]

16. A medical practitioner shall indicate the term of validity of the prescription in accordance with the diagnosis and medicinal products to be prescribed.

17. A pharmacist or pharmacist's assistant who dispenses the medicinal products shall indicate the code (registration number in the Latvian Medicinal Product Register by indicating the identification number of the product) or name assigned by the manufacturer (by indicating the size of the package), the quantity (number of packages), price (of one package) of the medicinal products dispensed, the amount intended for payment (taking into account the number of packages) and the prescription closing date. A pharmacist or pharmacist's assistant shall approve this information on the prescription form by a signature and personal stamp.

18. Dispensing the medicinal products on the basis of a multiple-use prescription, the pharmacist or pharmacist's assistant shall make a mark on the reverse side of the prescription form regarding the quantity dispensed and the date of dispensation by attesting the notation by a signature and a personal stamp, and shall ensure the possibility to identify the pharmacy where the medicinal products were dispensed.

III. Requirements for Filling out Special Prescriptions

19. A doctor shall indicate the type of E or S form if a prescription has been written out to a citizen of another Member State of the European Union, Norway, Iceland, Liechtenstein or Switzerland in accordance with the international agreement which provides for mutual settlements for the health care services provided.

20. A pharmacist or pharmacist's assistant who issues the medicinal products, taking into account the contract entered into with the insurance company and the conditions of the insurance policy, shall indicate the name of insurance company and the amount of the compensation, if the insurance company compensates the patient for supply of the medicinal products.

21. A doctor shall indicate the category or amount of the State compensation if the medicinal products or medical devices are written out on a prescription in accordance with the specified compensation procedures.

22. The doctor shall indicate the diagnosis code in conformity with the ICD classification on all special prescriptions. In prescribing glycemia test strips for pregnant women the code "Z33" shall be indicated in addition to the primary diagnosis.

22.1 [2 June 2008]

23. A pharmacist or pharmacist's assistant who dispenses the medicinal products shall indicate the code (the identification number of the medicinal product in the list of compensated medicinal products for medicinal products distributed within the scope of the procedures for compensation, or in other cases - the registration number of the medicinal product in the Latvian Medicinal Product Register with a product identification number) or name assigned by the manufacturer of the medicinal products (the name shall be indicated if the medicinal product is not included in the Latvian Medicinal Product Register, and supplement with information regarding the size of package), quantity (number of packages), price (of one package) of the medicinal products dispensed, the amount intended for payment (taking into account the number of packages), the allocation thereof between patient and other payer, as well as the date of medicinal product dispensation. A pharmacist or pharmacist's assistant shall approve this information on the prescription form by a signature and personal stamp. If the quantity to be dispensed is not in full packages, the quantity of packages shall be indicated in decimals with a precision of up to four figures after the decimal point.

IV. Additional Requirements for Filling out Prescription Forms if a Patient has Informed that he or she will Use a Prescription in any of the European Union, European Economic Area states and the Swiss Confederation

24. The date of birth of a patient shall be indicated in the information on a patient.

25. Additional details (e-mail address and phone or fax number (with a country code)) shall be indicated in the information regarding a medical practitioner.

26. When prescribing medicinal products, one of the following names shall be provided:

26.1. international non-proprietary name of the medicinal products or, if none, the generally accepted name of the medicinal products;

26.2. the name assigned by the manufacturer of the medicinal products if it is prohibited to substitute medicinal products by striking off crosswise the area "Zāles atļauts aizvietot" [It is permitted to substitute the medicinal products] and indicating the justification of such prohibition;

26.3. the name assigned by the manufacturer of the medicinal product if biological medicinal products are prescribed.

Minister for Health G. Bērziņš

 

Annex 4
Cabinet Regulation No. 175
8 March 2005

Medicinal products Permitted to Write out on an Ordinary Prescription Form for Treatment Course of More than Three Months

[5 January 2016]

No.

Anatomical therapeutic chemical group of medicinal products Exceptions (medicinal products permitted to be prescribed on a single prescription for a treatment course of not more than three months)
1. Gastrointestial Tract and Metabolism
1.1. Agents for treatment of functional gastrointestinal disorders A03BA01 Atropine

A03BA03 Hyoscyamine

A03FA02 Cisapride

1.2. Agents for treatment of liver diseases and bile production or bile flow disorders  
1.3. Agents for diabetes treatment (A10)  
2. Blood and Haemopoietic Organs
2.1. Antithrombotic agents (B01AC07 Dipyridamole)  
3. Cardiovascular System
3.1. Vasodilators to be utilised for treatment of heart diseases (C01D)  
3.2. Antihypertensive agents (C02) C02BA01 Trimetaphan

C02CC02 Guanethidine

C02CC04 Debrisoquine

C02DA01 Diazoxide

3.3. Diuretic agents (C03)  
3.4. Beta blockers (C07)  
3.5. Calcium channel blockers (C08) C08EA02 Bepridil

C08EX01 Lidoflazine

3.6. Renine-angiotensine system influencing agents (C09)  
3.7. Serum lipid level reducing agents (C10) C10AX02 Probucol

C10AX09 Ezetimibe

4. Urogenital System and Sexual Hormones
4.1. Hormonal contraceptive agents for systematic use (G03A)  
4.2. Oestrogens (G03CA, natural and semi-synthetic)  
4.3. Combinations of oestrogens (G03CC04 Estrone, G03CC06 Estriol)  
4.4. Progestagens (G03D) G03DA01 Gestonorone

G03DB02 Megestrol

G03DB04 Nomegestrol

4.5. Combinations of progestagens and oestrogens (G03F) G03FB03 Chlormadinone and Estrogen
4.6. Urological agents including spasmolythic agents (G04B) G04BE01 Alprostadil
5. Systemic Hormone-Containing Agents Except Sexual Hormones and Insulins
5.1. Agents containing thyroid gland hormone (H03A)  
5.2 Antithyroid agents (H03B)  
5.3. Antiparathyroid hormones (H05B)  
6. Muscle and Skeleton System
6.1. Anti-inflammatory and antirheumatic agents, non-steroidal (M01AA, M01AB, M01AC, M01AE, M01AG, M01AX) M01AA02 Mofebutazone

M01AX17 Nimesulide

6.2. Central acting muscle relaxants (M03B)  
6.3. Antigout agents (M04A) M04AB03 Benzbromarone
7. Nervous system
7.1. Antimigraine agents, alkaloids (N02CA)  
7.2. Antiepileptic agents (N03) N03AG04 Vigabatrin

N03AX10 Felbamate

7.3. Antiparkinson agents (N04) N04BA Dopa and dopa derivatives
8. Respiratory System
8.1. Agents for treatment of obstructive airways diseases, adrenergic agents, inhalable agents (R03A) R03AA01 Epinephrine

R03AK01 Epinephrine in combinations

8.2. Other agents for treatment of obstructive airways diseases, inhalable agents (R03BB, R03BC, R03BX)  
8.3. Other agents for treatment of obstructive airways diseases, systemic agents (R03DA, R03DB, R03DX) R03DA04 Theophylline

R03DA74, R03DB04 Theophylline in combinations

9. Sense Organs
9.1. Antiglaucoma and myotic agents (S01E) S01EA05 Brimonidine

S01EB03 Ecothiopate

S01EB04 Demecarium

S01EB08 Aceclidine

Minister for Health G. Bērziņš

 

Annex 5
Cabinet Regulation No. 175
8 March 2005

Maximum Amount of Narcotic and Equivalent Psychotropic Substances Permitted to Write out on a Single Prescription

[12 April 2011; 29 November 2016]

No. International name of the substance Maximum amount of substance permitted to be prescribed on a prescription (in grams) Pharmaceutical form (it shall be applied according to the type of administration for the medicinal products manufactured in pharmacies) Notes
1. Buprenorphine hydrochloride 0.24 adhesive plasters, tablets no more than 12 adhesive plasters
2. Cyclobarbital calcium salt 1.0 tablets  
3. Dihydrocodeine tartrate 6.72 tablets  
4. Ethylmorphine 1.0    
5. Fentanyl 0.384 adhesive plasters no more than 20 adhesive plasters
6. Fentanyl citrate form 0.024 tablets, nasal spray  
7. Hydromorphone hydrochloride 6.4    
8. Codeine phosphate hemihydrate 3.0 tablets  
9. Methylphenidate hydrochloride 1.62 tablets  
10. Morphine hydrochloride 0.4 injection solution  
11. Morphine hydrochloride 6.0 tablets  
12. Morphine sulphate 10.8 tablets  
13. Oxycodone hydrochloride 4.48 tablets  
14. Pethidine hydrochloride 1.0 injection solution  
15. Pentazocine 0.3    
16. Trimeperidine hydrochloride 0.4 injection solution  
17. Ephedrine hydrochloride 0.5    

 

Annex 6
Cabinet Regulation No. 175
8 March 2005

Generally Accepted Prescription Abbreviations

No.

Full designation in Latin Abbreviation Designation in Latvian
1. acidum acid., ac. skābe [acid]
2. adde   pievieno, piejauc [add, admix]
3. ad manum medici ad man. med. ārsta rokās [in the hands of a doctor]
4. ad usum externum ad us. ext. ārīgai lietošanai [for external use]
5. ad usum internum ad us. int. iekšķīgai lietošanai [for internal use]
6. ad usum proprium ad us. propr. personīgai lietošanai [for personal use]
7. ad vitrum ad vitr. stikla traukā [in a glass container]
8. aequalis aeq. vienāds [equal]
9. ampulla amp., ampull. ampula [ampoule]
10. ana āā līdzīgās daļās, pa [in equal parts, by]
11. anhydricus anhydr. bezūdens [waterless]
12. aqua aq. ūdens [water]
13. aqua destillata aq. dest. destilētais ūdens [distilled water]
14. butyrum butyr. sviests [butter]
15. compositum comp. salikts [compound]
16. capsula amylacea caps. amyl. cietes kapsula [starch capsule]
17. capsula gelatinosa caps. gel. želatīna kapsula [gelatine capsule]
18. charta chart. papīrs [paper]
19. charta cerata chart. cer. vaskots papīrs [wax paper]
20. charta paraffinata chart. paraff. parafīna papīrs [paraffin paper]
21. concentratus conc. koncentrēts [concentrated]
22. cortex cort. miza [peel]
23. crystallisatus cryst. kristālisks [crystalline]
24. cum c. ar [with]
25. Da; Detur; Dentur D. dod; lai tiek dots; lai tiek doti [give; to be given]
26. Da in scatula D. in scat. dod kārbiņā [to be given in a box]
27. Da in vitro D. in vitr. dod stikla traukā [to be given in a glass container]
28. Da in vitro nigro D. in vitro nigro dod tumšā traukā [to be given in a dark container]
29. Da, Signa; Dentur, Signetur D.S. dod, apzīmē; lai tiek dots, lai tiek apzīmēts [give, designate; to be given, to be designated]
30. Da tales doses;

Dentur tales doses

D.t.d. dod tādas devas; lai tiek dotas tādas devas; izsniegt šādas devas [give such doses; to be given such doses; to dispense the following doses]
31. decoctum dec. novārījums [decoction]
32. depuratus dep. attīrīts [purified]
33. destillatus destill. destilēts [distilled]
34. dilutus dil. atšķaidīts [diluted]
35. divide in partes aequales div. in p. aeq. sadali vienādās devās; sadali līdzīgās devās [divide in equal parts; divide in similar parts]
36. dosis d., dos. deva [dose]
37. emplastrum empl. plāksteris [adhesive plaster]
38. emulsum, emulsio emuls. emulsija [emulsion]
39. extractum extr. ekstrakts, izvilkums [extract; essence]
40. extractum fluidum extr. fl. šķidrais ekstrakts [liquid extract]
41. extractum siccum extr. sicc. sausais ekstrakts [dry extract]
42. extractum spissum extr. spiss. biezais ekstrakts [thick extract]
43. fiat (fiant) f. lai pagatavotu, lai top, lai veidotos [in order to prepare, let it become, in order to form]
44. flores fl. ziedi [flowers]
45. folium fol. lapa [leaf]
46. fructus fr. auglis [fruit]
47. gelatina gel. želatīna [gelatine]
48. globulus glob. lodīte [pellet]
49. gutta, guttae gtt. piliens, pilieni [droplet, droplets]
50. guttas gtts pilienus [droplets]
51. herba hb. laksti, zāle [tops, grass]
52. in ampullis in amp., ampull. ampulās [in ampoules]
53. infusum inf. uzlējums [infusion]
54. in capsulis in caps. kapsulās [in capsules]
55. in oblatis in obl. oblatēs [in cachet shell]
56. in tabulettis in tab., in tabul. tabletēs [in pellets]
57. linimentum lin., linim. šķidrā ziede, liniments [liquid ointment, liniment]
58. liquor, liquidus liq. šķidrums, šķidrs [liquid element, fluidal]
59. massa m. masa [mass]
60. massa pilularum m. pil. zirnīšu masa [mass of pillules]
61. Misce; Misceatur M. sajauc; lai tiek sajaukts, samaisīts [mix; let it be mixed, blended]
62. Misce.Da.Signa;

Misceatur, Detur, Signetur

M.D.S. sajauc, dod, apzīmē; lai tiek sajaukts, dots, apzīmēts [mix, give, designate; let it be mixed, given, designated]
63. Misce fiat M.f. sajauc, lai top [mix; let it become]
64. mixtura mixt. mikstūra [mixture]
65. mucilago muc. gļotas [mucus]
66. numero N. skaitā [in number]
67. oleum ol. eļļa [oil]
68. pars, partes p. daļa, daļas [part, parts]
69. partes aequales p. aeq. vienādas daļas, vienādās (līdzīgās) devās [equal parts, equal (similar) parts]
70. paste past. paste
71. pilula, pilulae pil. zirnītis, zirnīši [pillule, pillules]
72. praecipitatus ppt., praec. izgulsnēts - nogulsnes [precipitated - sediment]
73. pro injectionibus pro inj. iešļircināšanai [for injection]
74. pro usu externo pro us. ext. ārīgai lietošanai [for external use]
75. pro usu interno pro us. int. iekšķīgai lietošanai [for internal use]
76. pulvis, pulveres pulv. pulveris [powder]
77. purus pur. tīrs [pure]
78. quantum satis q.s. cik vajag; vajadzīgajā daudzumā [in the amount required]
79. radix rad. sakne [root]
80. Recipe Rp. ņem [take]
81. repete, repetatur repet. atkārtot; lai tiek atkārtots [repeat; to be repeated]
82. rhizoma rhiz. saknenis, zemes stumbrs [rhizome; rootstock]
83. satis s. diezgan, pietiekami [enough; sufficient]
84. semen sem. sēklas [seeds]
85. seu, sive s. jeb [or]
86. siccus sicc. sauss [dry]
87. Signa, Signetur S. apzīmē; lai tiek apzīmēts [designate; to be designated]
88. simplex simpl. vienkāršs [simple]
89. sirupus sir. sīrups [syrup]
90. solutio sol. šķīdums [solution]
91. species spec. zāļu tēja [herbal tea]
92. spiritus spir. spirts [alcohol]
93. sublimatus subl. sublimēts [sublimated]
94. subtilis subt. smalks [subtle]
95. subtilissimus subtiliss. vissmalkākais [the subtlest]
96. suppositorium supp. svecītes [suppositories]
97. suppositorium rectale supp. rect. svecīte, rektālais supozitorijs [suppository, rectal suppository]
98. suppositorium vaginale supp. vag. vaginālais supozitorijs [vaginal suppository]
99. tabuletta; tabulettae tab., tabul. tablete, tabletes [pill; pills]
100. tales t. tādas [such]
101. tinctura t-ra, tinct., tct. tinktūra [tincture]
102. unguentum ung. ziede [ointment]
103. verte V. apgriez [reverse]
104. vitrum vitr. stikla trauks, trauks [glass container; container]

Minister for Health G. Bērziņš

 

Annex 7
Cabinet Regulation No. 175
8 March 2005

Active Substances with High Pharmacovigilance Risk

[5 January 2016; 29 November 2016]

1. Isotretinoin

2. Talidomide

3. Lenalidomide

4. Pomalidomide

5. Acitretine

 


Translation © 2017 Valsts valodas centrs (State Language Centre)

 
Document information
Status:
In force
in force
Issuer: Cabinet of Ministers Type: regulation Document number: 175Adoption: 08.03.2005.Entry into force: 24.03.2005.Publication: Latvijas Vēstnesis, 48, 23.03.2005.
Language:
Related documents
  • Amendments
  • Changes legal status of
  • Issued pursuant to
104228
{"selected":{"value":"17.05.2019","content":"<font class='s-1'>17.05.2019.-...<\/font> <font class='s-3'>Sp\u0113k\u0101 eso\u0161\u0101<\/font>"},"data":[{"value":"17.05.2019","iso_value":"2019\/05\/17","content":"<font class='s-1'>17.05.2019.-...<\/font> <font class='s-3'>Sp\u0113k\u0101 eso\u0161\u0101<\/font>"},{"value":"01.10.2017","iso_value":"2017\/10\/01","content":"<font class='s-1'>01.10.2017.-16.05.2019.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.09.2017","iso_value":"2017\/09\/01","content":"<font class='s-1'>01.09.2017.-30.09.2017.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"30.08.2017","iso_value":"2017\/08\/30","content":"<font class='s-1'>30.08.2017.-31.08.2017.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.12.2016","iso_value":"2016\/12\/01","content":"<font class='s-1'>01.12.2016.-29.08.2017.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"15.01.2016","iso_value":"2016\/01\/15","content":"<font class='s-1'>15.01.2016.-30.11.2016.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"25.10.2013","iso_value":"2013\/10\/25","content":"<font class='s-1'>25.10.2013.-14.01.2016.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.06.2011","iso_value":"2011\/06\/01","content":"<font class='s-1'>01.06.2011.-24.10.2013.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.07.2009","iso_value":"2009\/07\/01","content":"<font class='s-1'>01.07.2009.-31.05.2011.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.01.2009","iso_value":"2009\/01\/01","content":"<font class='s-1'>01.01.2009.-30.06.2009.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"06.06.2008","iso_value":"2008\/06\/06","content":"<font class='s-1'>06.06.2008.-31.12.2008.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"09.02.2008","iso_value":"2008\/02\/09","content":"<font class='s-1'>09.02.2008.-05.06.2008.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.10.2007","iso_value":"2007\/10\/01","content":"<font class='s-1'>01.10.2007.-08.02.2008.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"24.03.2005","iso_value":"2005\/03\/24","content":"<font class='s-1'>24.03.2005.-30.09.2007.<\/font> <font class='s-2'>Pamata<\/font>"}]}
17.05.2019
87
0
  • Twitter
  • Facebook
  • Draugiem.lv
 
0
Latvijas Vestnesis, the official publisher
ensures legislative acts systematization
function on this site.
All Likumi.lv content is intended for information purposes.
About Likumi.lv
News archive
Useful links
Contacts
For feedback
Terms of service
Privacy policy
Cookies
RSS logo
Latvijas Vēstnesis "Everyone has the right to know about his or her rights."
Article 90 of the Constitution of the Republic of Latvia
© Official publisher "Latvijas Vēstnesis"
ISO 9001:2008 (quality management system)
ISO 27001:2013 (information security) Kvalitātes balva